🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A phase 1/2, open-label, safety and dosing study of autologous CART cells (...
Status
Recruiting
Location
Stanford University, Dept. of Dermatology
Start Date
2020-09-29
Trial ID
NCT04422912
Treatments Being Tested
RESET-MS: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT07006805
Treatments Being Tested
RESET-MG: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy ...
Status
Recruiting
Location
University of California Irvine
Start Date
2024-12-17
Trial ID
NCT06359041
RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CAB...
Status
Recruiting
Location
University of California Irvine - Accepting Adult Patients
Start Date
2023-12-20
Trial ID
NCT06154252
Treatments Being Tested
RESET-SSc: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy...
Status
Recruiting
Location
Yale University
Start Date
2024-07-02
Trial ID
NCT06328777
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy...
Status
Recruiting
Location
University of California Irvine
Start Date
2024-02-16
Trial ID
NCT06121297